XTL Biopharmaceuticals Ltd. (XTLB)
NASDAQ: XTLB · Real-Time Price · USD
0.9300
0.00 (0.00%)
Feb 11, 2026, 4:00 PM EST - Market closed
XTL Biopharmaceuticals Market Cap
XTL Biopharmaceuticals has a market cap or net worth of $8.59 million as of February 11, 2026. Its market cap has decreased by -64.97% in one year.
Market Cap
8.59M
Enterprise Value
8.40M
1-Year Change
-64.97%
Ranking
Category
Stock Price
$0.93
Market Cap Chart
Since August 31, 2005, XTL Biopharmaceuticals's market cap has decreased from $179.98M to $8.59M, a decrease of -95.23%. That is a compound annual growth rate of -13.82%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 10, 2026 | 8.59M | 20.55% |
| Dec 31, 2025 | 7.12M | -68.18% |
| Dec 31, 2024 | 22.38M | 322.69% |
| Dec 31, 2023 | 5.30M | -16.54% |
| Dec 29, 2022 | 6.35M | -57.67% |
| Dec 30, 2021 | 14.99M | -4.38% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| GridAI Technologies | 9.78M |
| Chemomab Therapeutics | 9.42M |
| Edesa Biotech | 9.33M |
| Evogene | 9.25M |
| NuCana | 9.24M |
| BioRestorative Therapies | 9.23M |
| Pulmatrix | 9.06M |
| SeaStar Medical Holding | 8.94M |